SPYRE THERAPEUTICS, INC. Other Noncash Income (Expense)
SPYRE THERAPEUTICS, INC. (SYRE) reported Other Noncash Income (Expense) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-02-19
- SPYRE THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- SPYRE THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2024-09-30 was $0.00.
- SPYRE THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2024-06-30 was $0.00.
- SPYRE THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2024-03-31 was $0.00.
- SPYRE THERAPEUTICS, INC. other noncash income (expense) for fiscal 2025 was $0.00.
- SPYRE THERAPEUTICS, INC. other noncash income (expense) for fiscal 2024 was $0.00.
- SPYRE THERAPEUTICS, INC. other noncash income (expense) for fiscal 2023 was -$15.00K.
- SPYRE THERAPEUTICS, INC. other noncash income (expense) for fiscal 2022 was -$426.00K, a 227.16% decline from fiscal 2021.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-19 | |||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $0.00 10-K · filed 2026-02-19 | ||
| 2024-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | $0.00 derived: sum of 2 quarters · filed 2024-11-18 | $0.00 10-Q/A · filed 2024-11-18 | $3.00K derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2024-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | $0.00 10-Q/A · filed 2024-11-18 | $3.00K derived: sum of 3 quarters · filed 2026-02-19 | -$9.00K derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2024-03-31 | $0.00 10-Q/A · filed 2024-11-18 | $3.00K derived: sum of 2 quarters · filed 2026-02-19 | -$9.00K derived: sum of 3 quarters · filed 2026-02-19 | -$13.00K derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2023-12-31 | $3.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-19 | -$9.00K derived: sum of 2 quarters · filed 2026-02-19 | -$13.00K derived: sum of 3 quarters · filed 2026-02-19 | -$15.00K 10-K · filed 2026-02-19 | ||
| 2023-09-30 | -$12.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | -$16.00K derived: sum of 2 quarters · filed 2024-11-18 | -$18.00K 10-Q/A · filed 2024-11-18 | -$93.00K derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | -$4.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | -$6.00K 10-Q/A · filed 2024-11-18 | -$81.00K derived: sum of 3 quarters · filed 2025-02-27 | -$439.00K derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | -$2.00K 10-Q/A · filed 2024-11-18 | -$77.00K derived: sum of 2 quarters · filed 2025-02-27 | -$435.00K derived: sum of 3 quarters · filed 2025-02-27 | -$426.00K derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | -$75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$433.00K derived: sum of 2 quarters · filed 2025-02-27 | -$424.00K derived: sum of 3 quarters · filed 2025-02-27 | -$426.00K 10-K · filed 2025-02-27 | $2.00K 10-K · filed 2023-03-02 | |
| 2022-09-30 | -$358.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$349.00K derived: sum of 2 quarters · filed 2023-11-09 | -$351.00K 10-Q · filed 2023-11-09 | $0.00 10-Q · filed 2022-11-03 | -$14.00K derived: sum of 4 quarters · filed 2024-11-18 | |
| 2022-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $7.00K 10-Q · filed 2023-08-11 | $344.00K derived: sum of 3 quarters · filed 2024-11-18 | $346.00K derived: sum of 4 quarters · filed 2024-11-18 | ||
| 2022-03-31 | -$2.00K 10-Q · filed 2023-05-11 | $335.00K derived: sum of 2 quarters · filed 2024-11-18 | $337.00K derived: sum of 3 quarters · filed 2024-11-18 | $333.00K derived: sum of 4 quarters · filed 2024-11-18 | ||
| 2021-12-31 | $337.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | $339.00K derived: sum of 2 quarters · filed 2024-11-18 | $335.00K derived: sum of 3 quarters · filed 2024-11-18 | $335.00K 10-K/A · filed 2024-11-18 | -$9.00K 10-K · filed 2022-03-08 | |
| 2021-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$2.00K derived: sum of 2 quarters · filed 2022-11-03 | -$2.00K 10-Q · filed 2022-11-03 | -$8.00K derived: sum of 4 quarters · filed 2023-03-02 | ||
| 2021-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$4.00K 10-Q · filed 2022-08-04 | -$10.00K derived: sum of 3 quarters · filed 2023-03-02 | -$10.00K derived: sum of 4 quarters · filed 2023-03-02 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | -$6.00K derived: sum of 2 quarters · filed 2023-03-02 | -$6.00K derived: sum of 3 quarters · filed 2023-03-02 | |||
| 2020-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$6.00K derived: sum of 2 quarters · filed 2023-03-02 | $9.00K 10-K · filed 2023-03-02 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $15.00K 10-Q · filed 2021-11-04 | ||||
| 2020-06-30 | $15.00K 10-Q · filed 2021-08-05 | |||||
| 2019-12-31 | $5.00K 10-K · filed 2022-03-08 | |||||
| 2019-03-31 | -$69.00K 10-Q · filed 2019-05-07 | -$59.00K derived: sum of 2 quarters · filed 2021-03-18 | -$49.00K derived: sum of 3 quarters · filed 2021-03-18 | -$40.00K derived: sum of 4 quarters · filed 2021-03-18 | ||
| 2018-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $20.00K derived: sum of 2 quarters · filed 2021-03-18 | $29.00K derived: sum of 3 quarters · filed 2021-03-18 | $40.00K 10-K · filed 2021-03-18 | ||
| 2018-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $19.00K derived: sum of 2 quarters · filed 2019-11-06 | $30.00K 10-Q · filed 2019-11-06 | $36.00K derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $20.00K 10-Q · filed 2019-08-06 | $26.00K derived: sum of 3 quarters · filed 2020-02-24 | $28.00K derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-03-31 | $11.00K 10-Q · filed 2019-05-07 | $17.00K derived: sum of 2 quarters · filed 2020-02-24 | $19.00K derived: sum of 3 quarters · filed 2020-02-24 | $27.00K derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2017-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $8.00K derived: sum of 2 quarters · filed 2020-02-24 | $16.00K derived: sum of 3 quarters · filed 2020-02-24 | $21.00K 10-K · filed 2020-02-24 | ||
| 2017-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $10.00K derived: sum of 2 quarters · filed 2018-11-08 | $15.00K 10-Q · filed 2018-11-08 | $9.00K derived: sum of 4 quarters · filed 2019-03-07 | ||
| 2017-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $13.00K 10-Q · filed 2018-08-09 | $7.00K derived: sum of 3 quarters · filed 2019-03-07 | $11.00K derived: sum of 4 quarters · filed 2019-03-07 | ||
| 2017-03-31 | $5.00K 10-Q · filed 2018-05-08 | -$1.00K derived: sum of 2 quarters · filed 2019-03-07 | $3.00K derived: sum of 3 quarters · filed 2019-03-07 | |||
| 2016-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$2.00K derived: sum of 2 quarters · filed 2019-03-07 | $10.00K 10-K · filed 2019-03-07 | |||
| 2016-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $16.00K 10-Q · filed 2017-11-07 | ||||
| 2016-06-30 | $12.00K 10-Q · filed 2017-08-09 | |||||
| 2015-12-31 | $19.00K 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |